{"id":"W4310127434","doi":"10.1182/blood-2022-157547","title":"Enduring Responses after 1-Year, Fixed-Duration Cevostamab Therapy in Patients with Relapsed/Refractory Multiple Myeloma: Early Experience from a Phase I Study","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University; University of Calgary; Princess Margaret Cancer Centre; Jewish General Hospital; University of Toronto","funders":"","keywords":"Multiple myeloma; Medicine; Lenalidomide; Refractory (planetary science); Internal medicine; Oncology; Pomalidomide; Bortezomib","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004360444,0.0005374144,0.001250424,0.0002240128,0.0004172779,0.00099635,0.0005990415,0.0005871329,0.0009590695],"category_scores_gemma":[0.00221292,0.00019361,0.0008469655,0.0003329571,0.0004575758,0.0005931451,0.0003436039,0.001564614,0.0003721799],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007589535,"about_ca_system_score_gemma":0.0007984636,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005939346,"about_ca_topic_score_gemma":0.001075374,"domain_scores_codex":[0.9990971,0.0004030302,0.00006629498,0.0001287628,0.0001454158,0.0001593803],"domain_scores_gemma":[0.9987116,0.0004550538,0.0002474983,0.0001240401,0.0001122166,0.0003495641],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.1162828,0.04572151,0.1028308,0.001043827,0.00235776,0.001339009,0.002946774,0.003298817,0.07017541,0.0004428656,0.005645039,0.6479154],"study_design_scores_gemma":[0.05071882,0.6834433,0.2165024,0.0003368606,0.001441734,0.003312081,0.0005570892,0.002317044,0.01784073,0.0004526892,0.02299646,0.00008075909],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9911384,0.006166172,0.0005574833,0.0001696179,0.00002461488,0.0003502632,0.0002769285,0.00002618639,0.001290292],"genre_scores_gemma":[0.9949485,0.002188285,0.000697314,0.0004908824,0.00004788496,0.0003125471,0.000836976,0.00001524843,0.000462282],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004360444,"threshold_uncertainty_score":0.0230605,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01930820697504737,"score_gpt":0.285848960289887,"score_spread":0.2665407533148396,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}